Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†-Reference-Cited by-同舟云学术

Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†

Published:2018-03-01 Issue:suppl_3 Volume:73 Page:iii2-iii78
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Hawkey Peter M¹,Warren Roderic E²,Livermore David M³,McNulty Cliodna A M⁴,Enoch David A⁵,Otter Jonathan A⁶,Wilson A Peter R⁷

Affiliation:

1. Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK

2. Shrewsbury and Telford Hospital NHS Trust, Telford, UK

3. Norwich Medical School, University of East Anglia, Norwich, UK

4. Microbiology Department, Gloucestershire Royal Hospital, Great Western Road, Gloucester GL1 3NN, UK

5. Public Health England, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

6. Imperial College London, UK

7. Department of Microbiology and Virology, University College London Hospitals, London, UK

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/suppl_3/iii2/24214345/dky027.pdf

Reference519 articles.

1. AGREE II: advancing guideline development, reporting and evaluation in health care;Brouwers;CMAJ,2010

2. Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party;Wilson;J Hosp Infect,2016

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-09-11

2. Valor del biomarcador tirosina quinasa 1 soluble tipo fms (sFLT-1) en el diagnóstico y pronóstico de la sepsis: una revisión sistemática;Medicina Clínica;2024-09

3. Value of the biomarker soluble tyrosine kinase 1 type fms (sFLT-1) in the diagnosis and prognosis of sepsis: a systematic review;Medicina Clínica (English Edition);2024-09

4. Does Two-Step Infusion Improve the Pharmacokinetics/Pharmacodynamics Target Attainment of Meropenem in Critically Ill Patients?;Journal of Pharmaceutical Sciences;2024-09

5. Metagenomic changes in response to antibiotic treatment in severe orthopedic trauma patients;iScience;2024-09